Fingerprint
Dive into the research topics of 'A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma
Patrick B. Johnston, David J. Inwards, Joseph P. Colgan, Betsy R. Laplant, Brian F. Kabat, Thomas M. Habermann, Ivana N. Micallef, Luis F. Porrata, Stephen M. Ansell, Craig B. Reeder, Vivek Roy, Thomas E. Witzig
Research output: Contribution to journal › Article › peer-review
184
Scopus
citations